EGFR and cancer: The ADC LR004-VC-MMAE demonstrated potent antitumor activity by suppressing EGFR signaling and downregulating cancer stemness-associated genes, suggesting its potential as a therapeutic candidate for EGFR-positive triple-negative BC [30].